Generation of clinical grade recombinant adeno-associated virus
Recombinant adeno-associated viruses (rAAV) remain one of the most encouraging gene therapy vectors for treating patients with genetic abnormalities. rAAV can safely deliver long-lasting expression of a therapeutic transgene to a wide range of cell types. One challenge with therapeutic rAAV is the...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/31279 |